Literature DB >> 30194852

Submicroscopic Plasmodium infection during pregnancy is associated with reduced antibody levels to tetanus toxoid.

C Álvarez-Larrotta1, O M Agudelo1, Y Duque1, K Gavina2, S K Yanow2,3, A Maestre1, J Carmona-Fonseca1, E Arango1.   

Abstract

Submicroscopic Plasmodium infections in pregnancy are common in endemic areas, and it is important to understand the impact of these low-level infections. Asymptomatic, chronic infections are advantageous for parasite persistence, particularly in areas where the optimal eco-epidemiological conditions for parasite transmission fluctuate. In chronic infections, the persistence of the antigenic stimulus changes the expression of immune mediators and promotes constant immune regulation, including increases in regulatory T cell populations. These alterations of the immune system could compromise the response to routine vaccination. This study aimed to evaluate the effect of submicroscopic plasmodial infection with P. falciparum and P. vivax during pregnancy on the immune response to the tetanus toxoid vaccine in Colombian women. Expression of different cytokines and mediators of immune regulation and levels of anti-tetanus toxoid (TT) immunoglobulin (Ig)G were quantified in pregnant women with and without submicroscopic plasmodial infection. The anti-TT IgG levels were significantly lower in the infected group compared with the uninfected group. The expression of interferon (IFN)-γ, tumour necrosis factor (TNF) and forkhead box protein 3 (FoxP3) was significantly higher in the infected group, while the expression of cytotoxic T lymphocyte antigen 4 (CTLA-4) and transforming growth factor (TGF)-β was lower in the group of infected. In conclusion, submicroscopic Plasmodium infection altered the development of the immune response to the TT vaccine in Colombian pregnant women. The impact of Plasmodium infections on the immune regulatory pathways warrants further exploration.
© 2018 British Society for Immunology.

Entities:  

Keywords:  zzm321990Plasmodiumzzm321990; cytokines; regulatory pathways; submicroscopic infections; vaccines

Mesh:

Substances:

Year:  2018        PMID: 30194852      PMCID: PMC6300694          DOI: 10.1111/cei.13213

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  56 in total

1.  Reduced cord blood immune effector-cell responsiveness mediated by CD4+ cells induced in utero as a consequence of placental Plasmodium falciparum infection.

Authors:  Kim Brustoski; Ulrike Moller; Martin Kramer; Franca C Hartgers; Peter G Kremsner; Urszula Krzych; Adrian J F Luty
Journal:  J Infect Dis       Date:  2005-11-30       Impact factor: 5.226

Review 2.  Role of Foxp3-positive regulatory T cells during infection.

Authors:  Yasmine Belkaid
Journal:  Eur J Immunol       Date:  2008-04       Impact factor: 5.532

Review 3.  [Effect of submicroscopic or polyclonal Plasmodium falciparum infection on mother and gestation product: systematic review].

Authors:  Eliana Arango; Amanda Maestre; Jaime Carmona-Fonseca
Journal:  Rev Bras Epidemiol       Date:  2010-09

Review 4.  Tolerance and exhaustion: defining mechanisms of T cell dysfunction.

Authors:  Andrea Schietinger; Philip D Greenberg
Journal:  Trends Immunol       Date:  2013-11-06       Impact factor: 16.687

5.  Clinical Outcomes of Submicroscopic Infections and Correlates of Protection of VAR2CSA Antibodies in a Longitudinal Study of Pregnant Women in Colombia.

Authors:  Kenneth Gavina; Sedami Gnidehou; Eliana Arango; Chloe Hamel-Martineau; Catherine Mitran; Olga Agudelo; Carolina Lopez; Aisha Karidio; Shanna Banman; Jaime Carmona-Fonseca; Ali Salanti; Nicaise Tuikue Ndam; Michael Hawkes; Amanda Maestre; Stephanie K Yanow
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

6.  The effect of prophylaxis with chloroquine and proguanil on delayed-type hypersensitivity and antibody production following vaccination with diphtheria, tetanus, polio, and pneumococcal vaccines.

Authors:  A Gyhrs; B K Pedersen; I Bygbjerg; J Henrichsen; I Heron; I Petersen; P Skinhoj
Journal:  Am J Trop Med Hyg       Date:  1991-11       Impact factor: 2.345

7.  Plasmodium falciparum infection of the placenta impacts on the T helper type 1 (Th1)/Th2 balance of neonatal T cells through CD4(+)CD25(+) forkhead box P3(+) regulatory T cells and interleukin-10.

Authors:  C Bisseye; M van der Sande; W D Morgan; A A Holder; M Pinder; J Ismaili
Journal:  Clin Exp Immunol       Date:  2009-08-17       Impact factor: 4.330

8.  Malaria chemoprophylaxis and the serologic response to measles and diphtheria-tetanus-whole-cell pertussis vaccines.

Authors:  Jennifer B Rosen; Joel G Breman; Charles R Manclark; Bruce D Meade; William E Collins; Hans O Lobel; Pierre Saliou; Jacquelin M Roberts; Pierre Campaoré; Mark A Miller
Journal:  Malar J       Date:  2005-11-06       Impact factor: 2.979

9.  Distinct roles for FOXP3 and FOXP3 CD4 T cells in regulating cellular immunity to uncomplicated and severe Plasmodium falciparum malaria.

Authors:  Michael Walther; David Jeffries; Olivia C Finney; Madi Njie; Augustine Ebonyi; Susanne Deininger; Emma Lawrence; Alfred Ngwa-Amambua; Shamanthi Jayasooriya; Ian H Cheeseman; Natalia Gomez-Escobar; Joseph Okebe; David J Conway; Eleanor M Riley
Journal:  PLoS Pathog       Date:  2009-04-03       Impact factor: 6.823

10.  Protective role of programmed death 1 ligand 1 (PD-L1)in nonobese diabetic mice: the paradox in transgenic models.

Authors:  Chia-Jen Wang; Feng-Cheng Chou; Chi-Hong Chu; Jen-Chine Wu; Shih-Hua Lin; Deh-Ming Chang; Huey-Kang Sytwu
Journal:  Diabetes       Date:  2008-04-16       Impact factor: 9.461

View more
  2 in total

1.  Frequency of gestational malaria and maternal-neonatal outcomes, in Northwestern Colombia 2009-2020.

Authors:  Jaiberth Antonio Cardona-Arias; Jaime Carmona-Fonseca
Journal:  Sci Rep       Date:  2022-06-29       Impact factor: 4.996

2.  Congenital malaria: Frequency and epidemiology in Colombia, 2009-2020.

Authors:  Jaiberth Antonio Cardona-Arias; Jaime Carmona-Fonseca
Journal:  PLoS One       Date:  2022-02-18       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.